DHX40: Potential Drug Targets and Biomarkers (G79665)

Target Name: DHX40

NCBI ID: G79665

DHX40

DHX40: Potential Drug Targets and Biomarkers

DHX40 (double-stranded heat shock protein 40) is a protein that is expressed in various tissues and cells throughout the body. It is a heat shock protein, which means that it is produced in high levels when the body is subjected to heat or stress.

One of the unique features of DHX40 is its ability to interact with various signaling pathways, including the DNA damage response pathway. This is important because DNA damage can lead to the development of various diseases, including cancer.

DHX40 has also been shown to play a role in the regulation of cell proliferation. In fact, studies have shown that high levels of DHX40 can promote the growth and proliferation of cancer cells.

Another potential drug target for DHX40 is its role in the regulation of pain. DHX40 has been shown to play a role in the development of pain sensitivity, and it has also been shown to reduce the effects of pain medications. This suggests that DHX40 could be a potential drug target for pain relief.

DHX40 has also been shown to be involved in the regulation of inflammation. In fact, studies have shown that high levels of DHX40 can promote the production of inflammatory cytokines. This suggests that DHX40 could be a potential drug target for inflammation.

In addition to its potential drug targets, DHX40 is also of interest to researchers because of its ability to interact with various signaling pathways. This makes it an attractive target for small molecules, which can be used to modulate its activity.

Overall, DHX40 is a protein that has potential as a drug target or biomarker. Further research is needed to fully understand its role in various biological processes and to develop effective treatments.

Protein Name: DEAH-box Helicase 40

Functions: Probable ATP-dependent RNA helicase

The "DHX40 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DHX40 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets